ESSENTIAL DEFENSE MINERAL SHIELD BROAD SPECTRUM SPF 32 TINTED SUNSCREEN- titanium dioxide and zinc oxide lotion 
Allergan, Inc.

----------

Drug Facts

Active ingredients

Titanium Dioxide 5.0%

Zinc Oxide 6.0%

Purpose

Sunscreen

Sunscreen

Uses

Warnings

For external use only

Do not use

on damaged or broken skin

When using this product

keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor

if skin rash occurs

Keep out of reach of children.

If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredients

Water, Cyclopentasiloxane, Dimethicone, Polyglyceryl-3 Polydimethylsiloxyethyl Dimethicone, Butylene Glycol, Aluminum Hydroxide, Dimethicone/PEG-10/15 Cross polymer, PEG-9 Polydimethylsiloxyethyl Dimethicone, Sodium Chloride, Caffeine, Camellia Oleifera Leaf Extract, Tocopheryl Acetate, Sodium Citrate, Dimethicone/Vinyl Dimethicone Crosspolymer, Triethoxvsilylethyl Polydimethylsiloxyethyl Hexyl Dimethicone, PEG/PPG-18/18 Dimethicone, Triethoxycaprylylsilane, Stearic Acid, Ethylhexylglycerin, Phenoxyethanol, Iron Oxides (CI 77491, CI 77492, CI 77499)

Other information

Questions or comments?

www.skinmedica.com 

Principal Display Panel - Carton Label

SkinMedica®
ESSENTIAL
DEFENSE
MINERAL SHIELD™
BROAD SPECTRUM
SPF 32
SUNSCREEN
POST PROCEDURE &
SENSITIVE SKIN
TINTED
SUN PROTECTION
Net Wt. 1.85 Oz. / 52.5 g

SkinMedica®
ESSENTIAL 
DEFENSE
MINERAL SHIELD™
BROAD SPECTRUM 
SPF 32
SUNSCREEN 
POST PROCEDURE & 
SENSITIVE SKIN 
TINTED
SUN PROTECTION
Net Wt. 1.85 Oz. / 52.5 g

Principal Display Panel - Tube Label

SkinMedica®
ESSENTIAL
DEFENSE
MINERAL SHIELD™
BROAD SPECTRUM
SPF 32
SUNSCREEN
POST-PROCEDURE &
SENSITIVE SKIN
TINTED
SUN PROTECTION
Net Wt. 1.85 Oz. / 52.5 g

SkinMedica®
ESSENTIAL 
DEFENSE
MINERAL SHIELD™
BROAD SPECTRUM 
SPF 32
SUNSCREEN 
POST-PROCEDURE & 
SENSITIVE SKIN 
TINTED
SUN PROTECTION
Net Wt. 1.85 Oz. / 52.5 g

ESSENTIAL DEFENSE MINERAL SHIELD BROAD SPECTRUM SPF 32 TINTED SUNSCREEN 
titanium dioxide and zinc oxide lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-5675
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide50 mg  in 1 g
Zinc oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc oxide60 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
POLYGLYCERYL-3 POLYDIMETHYLSILOXYETHYL DIMETHICONE (4000 MPA.S) (UNII: RLA2U05Z4Q)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)  
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
CAMELLIA OLEIFERA LEAF (UNII: 5077EL0C60)  
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
CAFFEINE (UNII: 3G6A5W338E)  
DIMETHICONE/PEG-10/15 CROSSPOLYMER (UNII: 21AS8B1BSS)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0023-5675-171 in 1 CARTON03/16/2016
152.5 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:0023-5675-081 in 1 CARTON03/16/2016
2227 g in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:0023-5675-256 in 1 CARTON03/16/2016
37.1 g in 1 TUBE; Type 0: Not a Combination Product
4NDC:0023-5675-1312 in 1 CARTON03/16/2016
43.68 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02003/16/2016
Labeler - Allergan, Inc. (144796497)

Revised: 1/2019
Document Id: 8895bbf4-d277-43d1-9553-cb4e0e77f020
Set id: 279a5214-79b2-44e9-b003-378d0b992395
Version: 7
Effective Time: 20190101
 
Allergan, Inc.